Bibliografía del artículo
Calixto JB, Beirith A, Ferreira J, Santos AR, Filho VC, Yunes RA. Naturally occurring antinociceptive substances from plants. Phytother Res 14(6):401-418, 2000.
Calixto JB, Campos MM, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 69(2):973-983, 2004.
De Boer VC, Dihal AA, Van der Woude H, Arts IC, Wolffram GM, Alink GM, Rietjens IM, Keijer J, Hollman PC. Tissue distribution of quercetin in rats and pigs. J Nutr 135(7):1718-1725, 2005.
Fortunato LR, Alves CF, Teixeira MM, Rogerio AP. Quercetin: a flavonoid with the potential to treat asthma. Braz J Pharm Sci 48(4):589-599, 2012.
Middleton E, Chithan K, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52(4):673-751, 2000.
Mukherjee AB, Zhang Z. Allergic asthma: influence of genetic and environmental factors. J Biol Chem 286(38):32883-32889, 2011.
Papiris SA, Manali ED, Kolilekas L, Triantafillidou C, Tsangaris I. Acute severe asthma: new approaches to assessment and treatment. Drugs 69(17):2363-2391, 2009.
Potterat O, Hamburger M. Drug discovery and development with plant-derived compounds. Prog Drug Res 65(45):47-118, 2008.
Rainsford KD. Anti-inflammatory drugs in the 21st century. Subcell Biochem 42:3-27, 2007.
Rogerio AP, Dora CL, Andrade EL, Chaves JS, Silva LF, Lemos-Senna E, Calixto JB. Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice. Pharmacol Res 61(4):288-297, 2010. Rogerio, A.P, Fontanari, C, Borducchi, E, Keller, A.C, Russo, M., Soares, E.G, Albuquerque, D.A, Faccioli, L.H. Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma. Eur J Pharmacol, v.580, n.1-2, p.262-70, 2008., L.H. Anti-inflammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acid. J Pharm Pharmacol, v.58, n.9, p.1265-1273, 2006.
Rogerio AP, Kanashiro A, Fontanari C, Da Silva EV, Lucisano-Valim YM, Soares EG, Facioli LH. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm Res 56(10):402-408, 2007.
Rogerio AP, Sa-Nunes A, Albuquerque DA, Anibal FF, Medeiros AI, Machado ER, Souza AO, Prado JC Jr, Faccioli LH. Lafoensia pacari extract inhibits IL-5 production in toxocariasis. Parasite Immunol 25(7):393-400, 2003.
Rogerio AP, Sá-Nunes A, Faccioli LH. The activity of medicinal plants and secondary metabolites on eosinophilic inflammation. Pharmacol Res 62(4):298-307, 2010.
Sircar G, Saha B, Bhattacharya SG, Saha S. Allergic asthma biomarkers using systems approaches. Front Genet 8(4):308, 2014.
Sneader W. Drug discovery: a history by Walter Sneader. John Wiley and Sons, Ltd.: West Sussex, England, p.472, 2005.
Verpoorte R. Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discov Today 3(5):232-238, 1999.
Walle T, Walle UK, Halushka PV. Carbon dioxide is the major metabolite of quercetin in humans. J Nutr 131(10):2648-2652, 2001.